Impact of COVID-19 Pandemic on Orthopaedic Practice

Covid19 Clinical Trial

— COVERT  

Official title:

Impact of COVID-19 Pandemic on Orthopaedic Practice: the COVid-19 Emergency/Elective Related Trauma (COVERT) Collaborative

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05026788
• Other study ID #: 1414607
• Status: Active, not recruiting
• Start date: March 17, 2020
• Est. completion date: April 30, 2022

Study information

• Verified date: October 2021
• Source: Imperial College Healthcare NHS Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The COVERT Collaborative is led by a group of academic surgeons that is looking into the impact of the unprecedented COVID-19 pandemic on Trauma and Orthopaedic practice. This will involve both trauma and elective procedures, as well as mortality rates, operative and anaesthetic case mix. The information will help to shape service reconfiguration and enhance patient-specific treatment especially in the threat of potential subsequent waves and future pandemics.

Description:

In response to the health crisis, it is the responsibility of clinicians to audit and collaborate in order to observe the impact of the pandemic on clinical practice. With the restructure of the health infrastructure, there is likely to be changes to the nature of acute referrals to Trauma and Orthopaedics, operative and anaesthetic casemix, polytrauma and open fractures as well as the role of technology to reduce viral transmission. Patient safety ought to be prioritised at all times but a national narrative is required to equip healthcare services to counter the pandemic at various time intervals post-social distancing and lockdown at 1.5, 3, 6, 12, 18 and 24 months. This will act as an audit to compare and contrast if the reconfiguration of healthcare services is abiding by the governmental, DoH, NHS, WHO, RCS and BOA (BOAST) policies and guidelines.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 5000
• Est. completion date: April 30, 2022
• Est. primary completion date: April 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• anyone presenting with orthopaedic trauma to the Emergency Department who has been referred to the on-call Trauma and Orthopaedic team for further management.

Exclusion Criteria:

• spinal trauma

Related Conditions & MeSH terms

• Anesthesia
• COVID-19
• Covid19
• Morality
• Musculoskeletal Diseases
• Orthopedic Disorder
• Trauma

Intervention

Other:
• type of treatment
pathway of management for conservative treatment, operative treatment and type of anaesthesia used

Locations

Country	Name	City	State
United Kingdom	Imperial College Healthcare NHS Trust	London

Sponsors (1)

Lead Sponsor	Collaborator
Imperial College Healthcare NHS Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Park C, Sugand K, Nathwani D, Bhattacharya R, Sarraf KM. Impact of the COVID-19 pandemic on orthopedic trauma workload in a London level 1 trauma center: the "golden month". Acta Orthop. 2020 Oct;91(5):556-561. doi: 10.1080/17453674.2020.1783621. Epub 202 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Treatment	Non-operative vs operative management	duration of study
Primary	Mortality rate	For patients presenting with orthopaedic trauma	duration of study
Primary	Number of COVID positive patients	For patients presenting with orthopaedic trauma regardless of treatment pathway	duration of study